Amyloidosis is a rare disease in which insoluble amyloid proteins are deposited in tissues or organs, resulting in organ damage. The diagnosis and treatment of this disease remain a major challenge, with several novel agents being explored in clinical trials. Furthermore, clinicians and researchers are drawing attention to the important role of the multidisciplinary team (MDT) in the treatment and management of patients.
In this podcast, experts Meral Beksac, MD, Ankara University, Ankara, Turkey, Shaji Kumar, MD, Mayo Clinic, Rochester, MN, and Efstathios Kastritis, MD, University of Athens School of Medicine, Athens, Greece, discuss recent updates in the treatment and management of amyloidosis, and further highlight the importance of the MDT in this disease.
The post Updates in the treatment and management of amyloidosis and the importance of the multidisciplinary team appeared first on VJHemOnc.
